Utilizing nullomers in cell-free RNA for early cancer detection
Austin Montgomery, Georgios Christos Tsiatsianis, Ioannis Mouratidis, Candace S. Y. Chan, Μαρία Αθανασίου, Anastasios D. Papanastasiou, Verena Kantere, Nikos Syrigos, Ioannis Vathiotis, Konstantinos Syrigos, Nelson S. Yee, Ilias Georgakopoulos‐Soares
Abstract
Early detection of cancer can significantly improve patient outcomes; however, sensitive and highly specific biomarkers for cancer detection are currently missing. Nullomers are the shortest sequences that are absent from the human genome but can emerge due to somatic mutations in cancer. We examine over 10,000 whole exome sequencing matched tumor-normal samples to characterize nullomer emergence across exonic regions of the genome. We also identify nullomer emerging mutational hotspots within tumor genes. Finally, we provide evidence for the identification of nullomers in cell-free RNA from peripheral blood samples, enabling detection of multiple tumor types. We show multiple tumor classification models with an AUC greater than 0.9, including a hepatocellular carcinoma classifier with an AUC greater than 0.99.